Vanda Pharmaceuticals Inc (VNDA)
4.845
+0.18
(+3.97%)
USD |
NASDAQ |
Nov 04, 13:15
Vanda Pharmaceuticals Price to Book Value: 0.5206 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 0.5007 |
| October 31, 2024 | 0.4996 |
| October 30, 2024 | 0.4899 |
| October 29, 2024 | 0.5039 |
| October 28, 2024 | 0.5136 |
| October 25, 2024 | 0.4889 |
| October 24, 2024 | 0.4856 |
| October 23, 2024 | 0.5039 |
| October 22, 2024 | 0.5082 |
| October 21, 2024 | 0.5082 |
| October 18, 2024 | 0.5275 |
| October 17, 2024 | 0.5087 |
| October 16, 2024 | 0.5265 |
| October 15, 2024 | 0.5157 |
| October 14, 2024 | 0.5168 |
| October 11, 2024 | 0.477 |
| October 10, 2024 | 0.4738 |
| October 09, 2024 | 0.4803 |
| October 08, 2024 | 0.4824 |
| October 07, 2024 | 0.4835 |
| October 04, 2024 | 0.4975 |
| October 03, 2024 | 0.4835 |
| October 02, 2024 | 0.4932 |
| October 01, 2024 | 0.4878 |
| September 30, 2024 | 0.5039 |
| Date | Value |
|---|---|
| September 27, 2024 | 0.5018 |
| September 26, 2024 | 0.5093 |
| September 25, 2024 | 0.5211 |
| September 24, 2024 | 0.5329 |
| September 23, 2024 | 0.5104 |
| September 20, 2024 | 0.4953 |
| September 19, 2024 | 0.4996 |
| September 18, 2024 | 0.5318 |
| September 17, 2024 | 0.5308 |
| September 16, 2024 | 0.5458 |
| September 13, 2024 | 0.548 |
| September 12, 2024 | 0.5361 |
| September 11, 2024 | 0.5286 |
| September 10, 2024 | 0.5351 |
| September 09, 2024 | 0.5394 |
| September 06, 2024 | 0.5394 |
| September 05, 2024 | 0.5458 |
| September 04, 2024 | 0.5458 |
| September 03, 2024 | 0.5458 |
| August 30, 2024 | 0.5684 |
| August 29, 2024 | 0.5609 |
| August 28, 2024 | 0.5662 |
| August 27, 2024 | 0.5748 |
| August 26, 2024 | 0.5899 |
| August 23, 2024 | 0.5866 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3581
Minimum
Nov 09 2023
2.486
Maximum
Jun 30 2021
1.222
Average
1.208
Median
Mar 25 2020
Price to Book Value Benchmarks
| Zevra Therapeutics Inc | 13.90 |
| Edgewise Therapeutics Inc | 6.233 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.110 |
Price to Book Value Related Metrics
| PS Ratio | 1.539 |
| Price | 4.845 |
| Earnings Yield | -3.87% |
| Market Cap | 282.41M |